Committee:

The Phase 2 study randomises 222 NZ/Australian rectal cancer patients to 90 days of simvastatin 40mg or placebo, starting a week before they begin pre-op chemo radiotherapy. The primary outcome is the proportion of favourable grade results on preoperative MRI with many secondary outcomes including reduced treatment toxicity. ................
................